Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma

Satish Noonepalle(Georgetown University), Alejandro Villagra(Georgetown University)
Journal of Experimental & Clinical Cancer Research
September 14, 2024
Cited by 19


Related Papers

Targeting HDAC6 improves anti-CD47 immunotherapy
|Journal of Experimental & Clinical Cancer Research|2024|21